CY1106031T1 - Συμπληρωμα διατροφης με "αδυνατιστικη" επιδραση - Google Patents

Συμπληρωμα διατροφης με "αδυνατιστικη" επιδραση

Info

Publication number
CY1106031T1
CY1106031T1 CY20071100222T CY071100222T CY1106031T1 CY 1106031 T1 CY1106031 T1 CY 1106031T1 CY 20071100222 T CY20071100222 T CY 20071100222T CY 071100222 T CY071100222 T CY 071100222T CY 1106031 T1 CY1106031 T1 CY 1106031T1
Authority
CY
Cyprus
Prior art keywords
effect
dietary supplement
slime
slimming
carnitine
Prior art date
Application number
CY20071100222T
Other languages
English (en)
Inventor
Franco Gaetani
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of CY1106031T1 publication Critical patent/CY1106031T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Confectionery (AREA)

Abstract

Ένα συμπλήρωμα διατροφής με μια «αδυνατιστική» επίδραση αποκαλύπτεται, το οποίο ενδυναμώνει το σκελετικό μυ, προστατεύοντας το καρδιαγγειακό σύστημα του χρήστη κι έχει ως τα χαρακτηριστικά συστατικά του το προπιονυλο-L-καρνιτίνη, το συνένζυμο Q10 νικοτιναμίδιο, ριβοφλαβίνη και παντοθενικό οξύ.
CY20071100222T 2001-01-29 2007-02-20 Συμπληρωμα διατροφης με "αδυνατιστικη" επιδραση CY1106031T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000044A ITRM20010044A1 (it) 2001-01-29 2001-01-29 Integratore alimentare ad effetto dimagrante.
PCT/IT2001/000304 WO2002060278A1 (en) 2001-01-29 2001-06-13 Food supplement with a slimming effect

Publications (1)

Publication Number Publication Date
CY1106031T1 true CY1106031T1 (el) 2011-04-06

Family

ID=11455161

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100222T CY1106031T1 (el) 2001-01-29 2007-02-20 Συμπληρωμα διατροφης με "αδυνατιστικη" επιδραση

Country Status (15)

Country Link
US (1) US8207109B2 (el)
EP (1) EP1355540B1 (el)
AT (1) ATE345699T1 (el)
AU (1) AU2001270980B2 (el)
CA (1) CA2434482C (el)
CY (1) CY1106031T1 (el)
DE (1) DE60124769T2 (el)
DK (1) DK1355540T3 (el)
ES (1) ES2271042T3 (el)
HU (1) HU228455B1 (el)
IT (1) ITRM20010044A1 (el)
MX (1) MXPA03006503A (el)
PL (1) PL201733B1 (el)
PT (1) PT1355540E (el)
WO (1) WO2002060278A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005031705A1 (de) * 2005-07-05 2007-01-18 Henkel Kgaa Mittel, enthaltend L-Carnitin oder L-Carnitinderivate und mindestens eine weitere Substanz ausgewählt aus Taurin und dessen Derivaten und mindestens einem Wirkstoff, erhältlich aus Pflanzen der Gattung Echinacea
CN102481270A (zh) 2009-05-11 2012-05-30 博格生物系统有限责任公司 利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗肿瘤障碍的方法
DE102009044975A1 (de) 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von Carnitin und Dihydroquercetin zur positiven Beeinflussung des natürlichen Pigmentierungsprozesses
DE102009044964A1 (de) 2009-09-24 2011-03-31 Henkel Ag & Co. Kgaa Verwendung einer Kombination aus Carnitin und/oder eines Carnitin-Derivats mit Purin und/oder einem Purin-Derivat zur Beeinflussung des natürlichen Pigmentierungsprozesses
AU2012240222B2 (en) 2011-04-04 2017-04-27 Berg Llc Methods of treating central nervous system tumors
WO2014045065A2 (en) * 2012-09-22 2014-03-27 Bslim Holdings Limited Dietary compositions and their uses
GB201304112D0 (en) * 2013-03-07 2013-04-24 Univ Nottingham Modulation of energy expenditure
AU2014251045B2 (en) 2013-04-08 2019-06-13 Berg Llc Treatment of cancer using coenzyme Q10 combination therapies
SG10201907816RA (en) 2013-09-04 2019-09-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
BR112018007434A2 (pt) 2015-10-27 2018-10-23 Cytozyme Animal Nutrition Inc composições para nutrição animal, usos e métodos relacionados

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298601A (en) * 1972-03-06 1981-11-03 Technutra, S.A. Method and formulations for the treatment of obesity
EP0150688B1 (en) 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
ZA904021B (en) * 1989-11-24 1991-02-27 Van Der Linde Leon Slimming preparations
GB9214247D0 (en) * 1992-07-04 1992-08-19 Stephan Peter M Composition for use as a food or food supplement
DE4410238A1 (de) 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
US5998457A (en) * 1995-10-26 1999-12-07 Avicena Group, Inc. Creatine analogues for treatment of obesity
IT1276253B1 (it) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
CA2243981C (en) * 1996-01-31 2005-09-06 South Alabama Medical Science Foundation Food and vitamin preparations containing the natural isomer of reduced folates
PL188558B1 (pl) * 1996-05-31 2005-02-28 Sigma Tau Ind Farmaceuti Sole L(-)karnityny i alkanoilo L(-)karnityn, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające takie sole
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6479069B1 (en) 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6562869B1 (en) * 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
IT1307278B1 (it) * 1999-11-18 2001-10-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil
DE10003493A1 (de) * 2000-01-27 2001-08-09 Wacker Chemie Gmbh Verfahren zur Herstellung eines Koezym Q10-/y-Cyclodextrin Komplexes
US6277842B1 (en) * 2000-10-17 2001-08-21 James Alexander Carthron Dietary supplemental method for fat and weight reduction

Also Published As

Publication number Publication date
EP1355540A1 (en) 2003-10-29
EP1355540B1 (en) 2006-11-22
DE60124769D1 (de) 2007-01-04
ATE345699T1 (de) 2006-12-15
WO2002060278A1 (en) 2002-08-08
MXPA03006503A (es) 2004-04-21
CA2434482C (en) 2009-09-08
AU2001270980B2 (en) 2007-01-18
HUP0302990A3 (en) 2005-04-28
US8207109B2 (en) 2012-06-26
ITRM20010044A0 (it) 2001-01-29
HUP0302990A2 (hu) 2003-12-29
PL201733B1 (pl) 2009-05-29
ES2271042T3 (es) 2007-04-16
ITRM20010044A1 (it) 2002-07-29
US20040028668A1 (en) 2004-02-12
DE60124769T2 (de) 2007-09-13
PL365253A1 (en) 2004-12-27
DK1355540T3 (da) 2007-04-02
CA2434482A1 (en) 2002-08-08
HU228455B1 (en) 2013-03-28
PT1355540E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
CY1106031T1 (el) Συμπληρωμα διατροφης με "αδυνατιστικη" επιδραση
IL173002A (en) Use of calcitonin in the manufacture of oral medication for the prevention or treatment of osteoarthritis
SV2004001904A (es) Cuerpos sinterizados a base de suboxido de niobio
AU2003273466A8 (en) Polyamino acids functionalized by at least one hydrophobic group and the therapeutic applications thereof
IT1318565B1 (it) Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e.
WO2004055084A3 (de) Copolyamide
MXPA04003499A (es) Utilizacion de cistationina.
IT1306133B1 (it) Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
MXPA02011465A (es) Sal de creatina que tiene eficacia terapeutica y nutricional mejorada y composiciones que contienen la misma.
ZA200408208B (en) Antiviral therapy on the basis of RNA interference.
AR027768A1 (es) Suplemento dietario para aportar energia a los musculos esqueleticos y proteger el aparato cardiovascular
BR0303428A (pt) Comutador de pé
ZA200303991B (en) "Polymerization".
DK1093337T3 (da) Næringsmiddelsupplementer omfattende liponsyre og creatin samt fremgangsmåder til anvendelse af disse
PL375417A1 (en) 2,3-dihydro-isoindol-1-ones with mao-b inhibiting activity
JP2004203970A5 (el)
TW200510461A (en) Disialoundecaglycosylasparagine - fatty acid amide and medicine containing the same
Schuld Influences on creativity: exploring an evolving process
Ahmadzadeh Misconceptions on the Issue of the Woman and the Qur'an, A Critique of the viewpoints of Muhammad Shahrur
TH69605S (th) ฐานขาชั้นวาง
TH27905S1 (th) ฐานขาชั้นวาง
EG23305A (en) Preparation of 1,2-dicloroethane.
ES1054820Y (es) Activador muscular facial
SI1532124T1 (sl) Uporaba nitrilnih derivatov kot zdravila
TH72805S (th) นาฬิกาแขวนหรือตั้งโต๊ะ